363 related articles for article (PubMed ID: 32016465)
21. Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway.
Sun T; Duan L; Li J; Guo H; Xiong M
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132355
[TBL] [Abstract][Full Text] [Related]
22. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
Oncotarget; 2014 May; 5(9):2853-63. PubMed ID: 24797310
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma.
Chowdhury SM; Lee T; Bachawal SV; Devulapally R; Abou-Elkacem L; Yeung TA; Wischhusen J; Tian L; Dahl J; Paulmurugan R; Willmann JK
J Control Release; 2018 Jul; 281():19-28. PubMed ID: 29758233
[TBL] [Abstract][Full Text] [Related]
24. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway.
Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A
Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract][Full Text] [Related]
26. Low intensity ultrasound promotes the sensitivity of rat brain glioma to Doxorubicin by down-regulating the expressions of p-glucoprotein and multidrug resistance protein 1 in vitro and in vivo.
Zhang Z; Xu K; Bi Y; Yu G; Wang S; Qi X; Zhong H
PLoS One; 2013; 8(8):e70685. PubMed ID: 23940624
[TBL] [Abstract][Full Text] [Related]
27. Piceatannol suppresses proliferation and induces apoptosis by regulation of the microRNA‑21/phosphatase and tensin homolog/protein kinase B signaling pathway in osteosarcoma cells.
Zheng M; Wu Y
Mol Med Rep; 2020 Nov; 22(5):3985-3993. PubMed ID: 32901863
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑93 inhibits the apoptosis and inflammatory response of tubular epithelial cells via the PTEN/AKT/mTOR pathway in acute kidney injury.
Zhan Y; Zhu M; Liu S; Lu J; Ni Z; Cai H; Zhang W
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296286
[TBL] [Abstract][Full Text] [Related]
29. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
Zhong T; Xu F; Xu J; Liu L; Chen Y
Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin combined with low intensity ultrasound suppresses the growth of oral squamous cell carcinoma in culture and in xenografts.
Fan H; Li H; Liu G; Cong W; Zhao H; Cao W; Zheng J
J Exp Clin Cancer Res; 2017 Nov; 36(1):163. PubMed ID: 29157266
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells.
Chen BW; Chen W; Liang H; Liu H; Liang C; Zhi X; Hu LQ; Yu XZ; Wei T; Ma T; Xue F; Zheng L; Zhao B; Feng XH; Bai XL; Liang TB
Mol Cancer Ther; 2015 Aug; 14(8):1805-15. PubMed ID: 26026051
[TBL] [Abstract][Full Text] [Related]
33. Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma.
Yan F; Wang C; Li T; Cai W; Sun J
Mol Med Rep; 2018 Mar; 17(3):4237-4244. PubMed ID: 29328455
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.
Rui M; Qu Y; Gao T; Ge Y; Feng C; Xu X
Int J Nanomedicine; 2017; 12():217-237. PubMed ID: 28115844
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
Xu J; Liu D; Niu H; Zhu G; Xu Y; Ye D; Li J; Zhang Q
J Exp Clin Cancer Res; 2017 Jan; 36(1):19. PubMed ID: 28126034
[TBL] [Abstract][Full Text] [Related]
37. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
[TBL] [Abstract][Full Text] [Related]
38. Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway.
Yuan P; Zheng A; Tang Q
Cell Biol Int; 2020 Jul; 44(7):1503-1513. PubMed ID: 32196840
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR‑141 deactivates hepatic stellate cells by targeting the PTEN/AKT/mTOR pathway.
Liang H; Wang X; Si C; Duan Y; Chen B; Liang H; Yang D
Int J Mol Med; 2020 Jul; 46(1):406-414. PubMed ID: 32319536
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of miR-25 attenuates doxorubicin-induced apoptosis, reactive oxygen species production and DNA damage by targeting PTEN.
Li Z; Li H; Liu B; Luo J; Qin X; Gong M; Shi B; Wei Y
Int J Med Sci; 2020; 17(10):1415-1427. PubMed ID: 32624698
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
